VIOLETTE SHELIA M. (Chief Scientific Officer) sold 4.9% of their position (2.99K shares) of Q32 BIO INC. on the open market
Open‑market sale worth $5.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/28/2025ACC: 0001193125-25-191447
Officer· Chief Scientific Officer
Since Feb 2026
-2.99K
Net shares
Net seller
$5.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.99K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.99K
Price / share
$1.80
Trade value
$5.38K
% of position
4.9%
8/26/2025
61.37K→58.38K
Total
Net shares
−2.99K
Net value
-$5.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2025 | S · Sale | −2.99K | $1.80 | $5.38K | 4.9% | 61.37K | 58.38K |
| Total | −2.99K | -$5.38K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned36.28K
Total
36.28K indirect36.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 36.28K | Indirect |
| Total | 36.28K | 36.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported